公共衛生學院: 公共衛生碩士學位學程指導教授: 楊銘欽李思慧Lee, Szu-HuiSzu-HuiLee2017-03-022018-06-292017-03-022018-06-292015http://ntur.lib.ntu.edu.tw//handle/246246/271656論文使用權限: 不同意授權間變性淋巴瘤激?（anaplastic lymphoma kinase, ALK)陽性率(Positive Rate)非小細胞肺癌(Non-Small Cell Lung Cancer)生物標記(biomarker)免疫組織化學染(immunohistochemistry, IHC)表皮生長因子接受器（epidermal growth factor receptor, EGFR）Anaplastic lymphoma kinasepositive ratenon-small cell lung cancerbiomarkerimmunohistochemistryepidermal growth factor receptor[SDGs]SDG3非小細胞肺癌治療新標的─調查台灣地區間變性淋巴瘤激?陽性率Novel Target in the Treatment of Non-small Cell Lung Cancer Anaplastic Lymphoma Kinase (ALK) Positive Rate of NSCLC in Taiwanthesis